AEterna Zentaris Inc. (AEZS)

[chmcnfunds]

Anyone read the CC transcript?

____________________________________________________
Question-and-Answer Session

Operator

[Operator Instructions] Your first question comes from Jason Kolbert with Maxim. Please go ahead.

Jason Kolbert - Maxim
Hi. Good morning, guys. Thanks for the rundown. A couple of questions, can you talk a little bit about what the product launch of the HRT patch is going to look like and help us understand what it is going to take to make that a bigger segment of the $3 billion market.

David Dodd - Chairman of the Board, President, Chief Executive Officer
Jason, I didn't understand when you said the patch. Do you mean, Estrogel?

Jason Kolbert - Maxim
Yes.

David Dodd - Chairman of the Board, President, Chief Executive Officer
Okay. Estrogel is not a patch. It is a clear gel.

Jason Kolbert - Maxim
Sorry. My mistake.
______________________________________
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111864886

Jason Kolbert of Maxim is the analysts who is touting AEZS

Regarding completion of Phase III:
_________________________________________

Richard Sachse - Senior Vice President, Chief Scientific Officer, Chief Medical Officer
Yes. Thanks, David. First of all, let me confirm with you that the improvement is going very well. We have now about 20 patients enrolled in the study, so we are very well in line with the goals that we announced that we will have the interim analysis the first one in the first half of this year and the second one in the second half of this year and have the trial completed by the end of next year.
_______________________________________

I thought according to to the Clinical Trials data it was to be sooner. If completed by the end of 2016, then results might not be announced until 2017.

(I have no shares)

AEZS